- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
People
Chris Yook is a senior associate in the Antitrust practice of King & Spalding. He advises clients on the antitrust implications of strategic business decisions, including securing approvals for mergers and acquisitions. Chris also represents clients in complex civil litigation, including some of the largest class actions. His recent matters include obtaining one of the first dismissals of a corporate defendant in the In re Generic Pharmaceuticals Pricing Antitrust Litigation.
Chris is recommended in the Legal 500 US guide and he has been named a “Rising Star” for antitrust litigation in Washington SuperLawyers from 2016 through 2020. He currently serves as Vice-Chair of the Content Committee in the ABA Section of Antitrust Law. Chris also sits on the executive board of the Asian Pacific American Bar Association of Maryland and is an American Bar Foundation Fellow.
Publications
- Contributor, Antitrust Law Developments (8th ed.)
- Contributor, 2018 Annual Review of Antitrust Law Developments
- Contributor, 2017 Annual Review of Antitrust Law Developments
- Editor, Health Care Antitrust Week-In-Review
- Antitrust Post-Mortem of the Health Insurance Merger Decisions, American Health Lawyers Association
- Benchmarking and Information Exchange: A Survey of U.S. Antitrust Laws, ABA Section of Antitrust Law, Spring Meeting 2017
- Avoiding Failure: Applying Decision Theory to the Eminent Domain Jurisprudence, 20 Fed. Cir. B.J. 443 (2011)
Credentials
J.D., George Washington University Law School, with honors
B.A., Johns Hopkins University
District of Columbia
Maryland
U.S. Court of Appeals for the Federal Circuit
U.S. Court of International Trade
U.S. District Court for the Eastern District of Michigan
Close
Recognition
Recommended in Legal 500
Legal 500 US Antitrust
Rising Star
Super Lawyers, 2016-2020
Ones to Watch, Antitrust Law
Best Lawyers, 2021
News
In the News · Source: Law360 and Bloomberg Law
In the News · Source: Reorg
Recognition
August 21, 2020
The Best Lawyers in America Recognizes 128 King & Spalding Lawyers in its 2021 Guide
Matters
Obtained dismissal Porsche Cars North America, Inc. and Dr. Ing. H.C. F. Porsche AG from multidistrict litigation alleging antitrust conspiracy over technological advancements, features, and costs (In re German Automotive Manufacturers Antitrust Litigation).
Successfully represented WestRock Company in its $4.9 billion acquisition of KapStone Paper & Packaging as part of investigation by the U.S. Department of Justice, Antitrust Division. The transaction was cleared without an enforcement action.
Counseled Oschner Health System in an antitrust investigation of a joint operating agreement with Slidell Memorial Hospital.
See more
Close
Matters
Obtained dismissal Porsche Cars North America, Inc. and Dr. Ing. H.C. F. Porsche AG from multidistrict litigation alleging antitrust conspiracy over technological advancements, features, and costs (In re German Automotive Manufacturers Antitrust Litigation).
Successfully represented WestRock Company in its $4.9 billion acquisition of KapStone Paper & Packaging as part of investigation by the U.S. Department of Justice, Antitrust Division. The transaction was cleared without an enforcement action.
Counseled Oschner Health System in an antitrust investigation of a joint operating agreement with Slidell Memorial Hospital.
Advised pharmaceutical company on antitrust implications of pricing policy.
Secured dismissal of generic pharmaceuticals manufacturer from price-fixing cartel multidistrict litigation (In re Generic Pharmaceuticals Pricing Antitrust Litigation).
Represented two Japanese automobile parts manufacturers in price-fixing cartel actions and government investigations spanning multiple jurisdictions (In re Automotive Parts Antitrust Litigation).
Counseled medical device manufacturer on antitrust issues related to development of product distribution policy.
Second-chaired jury trial, obtaining defense verdict for corporation in civil action involving fraud and misrepresentation claims.
Insights
Client Alert
May 4, 2020
Florida Oncology Provider to Pay $100 Million Fine in DOJ Criminal Antitrust Investigation
Client Alert
January 6, 2020
DOJ and Commerce Department Issue Antitrust Guidance on SEPs
Client Alert
October 25, 2019
Senators Urge DOJ to Develop Antitrust Guidance for Licensing of Standard Essential Patents
News
In the News · Source: Law360 and Bloomberg Law
In the News · Source: Reorg
Recognition
August 21, 2020
The Best Lawyers in America Recognizes 128 King & Spalding Lawyers in its 2021 Guide
Matters
Obtained dismissal Porsche Cars North America, Inc. and Dr. Ing. H.C. F. Porsche AG from multidistrict litigation alleging antitrust conspiracy over technological advancements, features, and costs (In re German Automotive Manufacturers Antitrust Litigation).
Successfully represented WestRock Company in its $4.9 billion acquisition of KapStone Paper & Packaging as part of investigation by the U.S. Department of Justice, Antitrust Division. The transaction was cleared without an enforcement action.
Counseled Oschner Health System in an antitrust investigation of a joint operating agreement with Slidell Memorial Hospital.
See more
Close
Matters
Obtained dismissal Porsche Cars North America, Inc. and Dr. Ing. H.C. F. Porsche AG from multidistrict litigation alleging antitrust conspiracy over technological advancements, features, and costs (In re German Automotive Manufacturers Antitrust Litigation).
Successfully represented WestRock Company in its $4.9 billion acquisition of KapStone Paper & Packaging as part of investigation by the U.S. Department of Justice, Antitrust Division. The transaction was cleared without an enforcement action.
Counseled Oschner Health System in an antitrust investigation of a joint operating agreement with Slidell Memorial Hospital.
Advised pharmaceutical company on antitrust implications of pricing policy.
Secured dismissal of generic pharmaceuticals manufacturer from price-fixing cartel multidistrict litigation (In re Generic Pharmaceuticals Pricing Antitrust Litigation).
Represented two Japanese automobile parts manufacturers in price-fixing cartel actions and government investigations spanning multiple jurisdictions (In re Automotive Parts Antitrust Litigation).
Counseled medical device manufacturer on antitrust issues related to development of product distribution policy.
Second-chaired jury trial, obtaining defense verdict for corporation in civil action involving fraud and misrepresentation claims.
Insights
Client Alert
May 4, 2020
Florida Oncology Provider to Pay $100 Million Fine in DOJ Criminal Antitrust Investigation
Client Alert
January 6, 2020
DOJ and Commerce Department Issue Antitrust Guidance on SEPs
Client Alert
October 25, 2019
Senators Urge DOJ to Develop Antitrust Guidance for Licensing of Standard Essential Patents
News
In the News · Source: Law360 and Bloomberg Law
In the News · Source: Reorg
Recognition
August 21, 2020
The Best Lawyers in America Recognizes 128 King & Spalding Lawyers in its 2021 Guide
Credentials
J.D., George Washington University Law School, with honors
B.A., Johns Hopkins University
District of Columbia
Maryland
U.S. Court of Appeals for the Federal Circuit
U.S. Court of International Trade
U.S. District Court for the Eastern District of Michigan
Close
Recognition
Recommended in Legal 500
Legal 500 US Antitrust
Rising Star
Super Lawyers, 2016-2020
Ones to Watch, Antitrust Law
Best Lawyers, 2021